Abstract
Background
Histological subdivision into typical (TC) and atypical (AC) is crucial for treatment and prognosis of lung carcinoids but can be also very challenging, even for experts. In this study, we aimed to strengthen or reduce the prognostic value of several pathological, clinical, or per-operative factors some of which are still controversial.
Methods
We retrospectively reviewed clinical records related to 195 patients affected by TC (159) or AC (36) surgically treated between 2000 and 2014, in three different centers. Survival and subtypes comparison analyses were performed to identify potential prognostic factors.
Results
TCs showed a lower rate of nodal involvement than ACs (N0 = 94.9%; N1 = 1.9%; N2 = 3.2% in typical and N0 = 63.8%; N1 = 16.6%; N2 = 19.4% in atypical carcinoids, respectively, p < 0.0001). Long-term oncological results of resected carcinoids were significantly better in TCs than ACs with higher 5- and 10-year overall survival rates (97.2 and 88.2% vs. 77.9 and 68.2%, respectively; p = 0.001) and disease-free survival rates (98.2 and 90.3% in typical and 80.8 and 70.7% atypical carcinoids, respectively; p = 0.001). Risk factors analysis revealed that AC subtype [HR 4.33 (95% CI 1.72–8.03), p = 0.002], pathological nodal involvement [HR 3.05 (95% CI 1.77–5.26), p < 0.0001], and higher SUVmax [HR 4.33 (95% CI 1.03–7.18), p = 0.002] were independently and pejoratively associated with overall survival. Factors associated with a higher risk of recurrence were AC subtype [HR 6.13 (95% CI 1.13–18.86), p = 0.002]; nodal involvement [HR 5.48 (95% CI 2.85–10.51), p < 0.0001]; higher Ki67 expression level [HR 1.09 (95% CI 1.01–1.20), p = 0.047]; and SUVmax [HR 1.83 (95% CI 1.04–3.23), p = 0.035].
Conclusion
Surgery for lung carcinoids allows satisfactory oncological results which mainly depend on carcinoid subtype dichotomy, pathological nodal status, and SUVmax.
Similar content being viewed by others
References
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumours in 35,825 cases in the United States. J Clin Oncol 20:3063–3072
Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB, Geisinger K, Hirsch FR, Ishikawa Y, Kerr KM, Noguchi M, Pelosi G, Powell CA, Tsao MS, Wistuba I, WHO Panel (2015) The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances Since the 2004 classification. J Thorac Oncol 10(9):1243–1260
Thomas CF, Tazelaar HD, Jett JR (2001) Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest 119:1143–1150
The IASLC Lung Cancer Staging Project (2008) Proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 3:1213–1223
Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Muguruza I (2015) ENETS consensus conference participants. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol 26(8):1604–1620
García-Yuste M, Matilla JM, Cueto A, Paniagua JM, Ramos G, Cañizares MA et al (2007) Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung for the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR) Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. Eur J Cardiothorac Surg. 31(2):192–197
Filosso PL, Rena O, Donati G, Casadio C, Ruffini E, Papalia E, Oliaro A, Maggi G (2002) Bronchial carcinoid tumors: surgical management and long-term outcome. J Thorac Cardiovasc Surg 123(3):03–09
Modlin IM, Sandor A (1997) An analysis of 8305 cases of carcinoid tumors. Cancer 79:813–829
Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC (2008) Risk factors associated with neuroendocrine tumors: a U.S.-based case–control study. Int J Cancer 123:867–873
Okike N, Bernatz PE, Woolner LB (1976) Carcinoid tumors of the lung. Ann Thorac Surg 22:270–277
Chughtai T, Morin J, Sheiner N, Wilson J, Mulder D (1997) Bronchial carcinoid. Twenty years’ experience defines a selective surgical approach. Surgery 122:801–818
Rea F, Rizzardi G, Zuin A, Marulli G, Nicotra S, Bulf R (2007) Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients. Eur J Cardiothorac Surg 31:186–191
Stefani A, Franceschetto A, Nesci J, Aramini B, Proli C, Kaleci S, Casolo A, Massi L, Casali C, Morandi U (2013) Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung. J Cardiothorac Surg 8:223
Jindal T, Kumar A, Venkitaraman B, Meena M, Kumar R, Malhotra A, Dutta R (2011) Evaluation of the role of [18F]FDG-PET/CT and [68 Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids. Cancer Imaging 8:70–75
Wartski M, Alberini JL, Leroy-Ladurie F, De Montpreville V, Nguyen C, Corone C, Dartevelle P, Pecking AP (2004) Typical and atypical bronchopulmonary carcinoid tumors on FDG-PET/CT imaging. Clin Nucl Med 8:752–753
Pattenden HA, Leung M, Beddow E, Dusmet M, Nicholson AG, Shackcloth M, Mohamed S, Darr A, Naidu B, Iyer S, Marchbank A, Greenwood A, West D, Granato F, Kirk A, Ariyaratnam P, Loubani M, Li E, UK Thoracic Surgery Collaborative (2015) Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours. Thorax 70(4):379–381
Lococo F, Treglia G, Cesario A, Paci M, Filice A, Versari A, Filosso PL (2014) Functional imaging evaluation in the detection, diagnosis, and histologic differentiation of pulmonary neuroendocrine tumors. Thorac Surg Clin 24:285–292
Ambrosini V, Nanni C, Zompatori M, Campana D, Tomassetti P, Castellucci P, Allegri V, Rubello D, Montini G, Franchi R, Fanti S (2010) (68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 37:722–727
Tastepe AI, Kurul IC, Demircan S, Iman ST, Kaya S, Cetin G (1998) Long-term survival following bronchotomy for polypoid bronchial carcinoid tumours. Eur J Cardiothorac Surg 14:575–577
Brokx HA, Paul MA, Postmus PE, Sutedja TG (2015) Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids. Thorax 70(5):468–472
Raz DJ, Nelson RA, Grannis FW, Kim JY (2015) Natural history of typical pulmonary carcinoid tumors: a comparison of nonsurgical and surgical treatment. Chest 147(4):1111–1117
Fox M, Van Berkel V, Bousamra M 2nd, Sloan S, Martin RC 2nd (2013) Surgical management of pulmonary carcinoid tumors: sublobar resection versus lobectomy. Am J Surg 205:200–208
Yendamuri S, Gold D, Jayaprakash V, Dexter E, Nwogu C, Demmy T (2011) Is sublobar resection sufficient for carcinoid tumors? Ann Thorac Surg 92:1774–1779
Cañizares MA, Matilla JM, Cueto A, Algar J, Muguruza I, Moreno-Mata N, Moreno-Balsalobre R, Guijarro R, Arrabal R, Garcia-Fontan E, Gonzalez-Piñeiro A, Garcia-Yuste M (2014) Atypical carcinoid tumours of the lung: prognostic factors and patterns of recurrence. Thorax 69:648–653
Gupta R, Dastane A, McKenna RJ Jr, Marchevsky AM (2009) What can we learn from the errors in the frozen section diagnosis of pulmonary carcinoid tumors? An evidence-based approach. Hum Pathol 40:1–9
Cafarotti S, Cesario A, Margaritora S, Granone P (2013) Typical bronchial carcinoid tumors: focus on surgical management. Ann Thorac Surg 95:381–387
Lim E, Goldstraw P, Nicholson AG, Travis WD, Jett JR, Ferolla P, Bomanji J, Rusch VW, Asamura H, Skogseid B, Baudin E, Caplin M, Kwekkeboom D, Brambilla E, Crowley J (2008) Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007. J Thorac Oncol 3:1194–1201
Cardillo G, Sera F, Di Martino M, Graziano P, Giunti R, Carbone L, Facciolo F, Martelli M (2004) Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg 77(5):1781–1785
Stolz A, Harustiak T, Simonek J, Schutzner J, Polanecky O, Burkert J, Lischke R (2015) Long-term outcomes and prognostic factors of patients with pulmonary carcinoid tumors. Neoplasma 62(3):478–483
Mineo TC, Guggino G, Mineo D, Vanni G, Ambrogi V (2005) Relevance of lymph node micrometastases in radically resected endobronchial carcinoid tumors. Ann Thorac Surg 80(2):428–432
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed were in accordance with the ethical standards of the each institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals.
Informed consent
Informed consent was obtained by patients or by their relatives in cases of deceased patients.
Rights and permissions
About this article
Cite this article
Cusumano, G., Fournel, L., Strano, S. et al. Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study—The Importance of Pathological N Status, More Than We Thought. Lung 195, 789–798 (2017). https://doi.org/10.1007/s00408-017-0056-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-017-0056-8